CD44 expression in the stromal matrix of colorectal cancer: Association with prognosis

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 21-29

  Furuta, Koh ^a   Zahurak, Marianna ^a   Goodman, Steven N ^a   Hamilton, Stanley R ^a   August, J Thomas ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADULT; AGE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; COLORECTAL CANCER; FEMALE; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; RACE; STATISTICAL ANALYSIS;

ADULT; AGED; ANIMALS; ANTIGENS, CD44; COLORECTAL NEOPLASMS; HUMANS; MICE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 0031882947     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Crissman, J. D., and Barwick, K. W. Pathologic staging of colon and rectal adenocarcinoma. In: H. J. Wanebo (ed.), Colorectal Cancer, pp. 57-74. St. Louis: Mosby-Year Book, 1993.
2. Lesley, J., Hyman, R., and Kincade, P. W. CD44 and its interaction with extracellular matrix. Adv. Immunol., 54: 271-335, 1993.
3. Jalkanen, S., Jalkanen, M., Bargatze, R., Tammi, M., and Butcher, E. C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol., 141: 1615-1623, 1988.
4. Stamenkovic, I., Amiot, M., Pesando, J. M., and Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family, Cell, 56: 1057-1062, 1989.
5. Belitsos, P. C., Hildreth, J. E., and August, J. T. Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J. Immunol., 144: 1661-1670, 1990.
6. Jacobson, K., O'Dell, D., Holifield, B., Murphy, T. L., and August, J. T. Redistribution of a major cell surface glycoprotein during cell movement. J. Cell Biol., 99: 1613-1623, 1984.
7. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell, 65: 13-24, 1991.
8. Penno, M. B., August, J. T., Baylin, S. B., Mabry, M., Linnoila, R. I., Lee, V. S., Croteau, D., Yang, X. L., and Rosada, C. Expression of CD44 in human lung tumor. Cancer Res., 54: 1381-1387, 1994.
9. Chaudhry, A., Eriksson, B., Skogseid, B., Oberg, K., and Gobl, A. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res., 54: 981-986, 1994.
10. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
11. Hudson, D. L., Speight, P. M., and Watt, F. M. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int. J. Cancer, 66: 457-463, 1996.
12. Salmi, M., Gron-Virta, K., Sointu, P., Grenman, R., Kalimo, H., and Jalkanen, S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol., 122: 431-442, 1993.
13. Favrot, M. C., Combaret, V., and Lasset, C. CD44: a new prognostic marker for neuroblastoma. N. Engl. J. Med., 329: 1965, 1993.
14. Matsumura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340: 1053-1058, 1992.
15. Heider, K. H., Hofmann, M., Hors, E., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120: 227-233, 1993.
16. Tanabe, K. K., Ellis, L. M., and Saya, H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341: 725-726, 1993.
17. Wielenga, V. J. M., Heider, K. H., Offerhaus, G. J. A., Adolf, G. R., van den Berg, F. M., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53: 4754-4756, 1993.
18. Finn, L., Dougherty, G., Finley, G., Meisler, A., Becich, M., and Cooper, D. L. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem. Biophys. Res. Commun., 200: 1015-1022, 1994.
19. Ichikawa, W. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology, 62: 172-179, 1994.
20. Mulder, J. W. R., Kruyt, P. M., Sewnath, M., Oosting, J., Seldenrijk, C. A., Weidema, W. F., Offerhaus, G. J. A., and Pals, S. T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344: 1470-1472, 1994.
21. Takeuchi, K., Yamaguchi, A., Urano, T., Goi, T., Nakagawara, G., and Shiku, H. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn. J. Cancer Res., 86: 292-297, 1995.
22. Orzechowski, H. D., Beckenbach, C., Herbst, H., Stolzel, U., Riecken, E. O., and Stallmach, A. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells. Eur. J. Cancer, 12: 2073-2079, 1995.
23. Goi, T., Yamaguchi, A., Takeuchi, K., Nakagawara, G., Yamashiro, S., Furukawa, K., Urano, T., Shiku, H., and Furukawa, K. CD44 with variant exons 8-10 in colorectal tumors: expression analysis by a variant exon 9-specific monoclonal antibody. Int. J. Oncol., 8: 657-662, 1996.
24. Gorham, H., Sugino, T., Woodman, A. C., and Tarin, D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J. Clin. Pathol., 49: 482-488, 1996.
25. Imazeki, F., Yokosuka, O., Yamaguchi, T., Ohto, M., Isono, K., and Omata, M. Expression of variant CD44 messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans, Gastroenterology, 110: 362-368, 1996.
26. Kawahara, K., Yoshino, T., Kawasaki, N., Miyake, K., and Akagi, T. Abnormal expression of the human CD44-gene in early colorectal malignancy with special reference to variant exon 9 (9v). J. Clin. Pathol., 49: 478-481, 1996.
27. Nihei, Z., Ichikawa, W., Kojima, K., Togo, S., Miyanaga, T., Hirayama, R., and Mishima, Y. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer. Surg. Today., 26: 760-761, 1996.
28. Yamaguchi, A., Urano, T., Goi, T., Saito, M., Takeuchi, K., Hirose, K., Nakagawara, G., Shiku, H., and Furukawa, K. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J. Clin. Oncol., 14: 1122-1127, 1996.
29. Mayer, B., Jauch, K. W., Gunthert, U., Figdor, C. G., Schildberg, F. W., Funke, I., and Johnson, J. P. De novo expression of CD44 and survival in gastric cancer. Lancet, 342: 1019-1022, 1993.
30. Gansauge, F., Gansauge, S., Zobywalski, A., Scharnweber, C., Link, K. H., Nussler, A. K., and Beger, H. G. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas, Cancer Res., 55: 5499-5503, 1995.
31. Kaufmann, M., Heider, K. H., Sinn, H. P., von Minckwitz, G., Ponta, H., and Herrlich, P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345: 615-619, 1995.
32. Dall, P., Heider, K. H., Hekele, A., von Minckwitz, G., Kaufmann, M., Ponta, H., and Herrlich, P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res., 54: 3337-3341, 1994.
33. Koopman, G., Heider, K. H., Horst, E., Adolf, G. R., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med., 177: 897-904, 1993.
34. Hong, R. L., Lee, W. J., Shun, C. T., Chu, J. S., and Chen, Y. C. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology. 52: 334-339, 1995.
35. Furuta, K., Zahurak, M., Yang, X. L., Rosada, C., Goodman, S. N., August, J. T., and Hamilton, S. R. The relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am. J. Pathol., 149: 1147-1155, 1996.
36. Iozzo, R. V. Tumor stroma as a regulator of neoplastic behavior: agonistic and antagonistic elements embedded in the same connective tissue. Lab. Invest., 73: 157-160, 1995.
37. Jen, J., Kim, H., Piantadosi, S., Liu, Z. F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer, N. Engl. J. Med., 331: 213-221, 1994.
38. Guo, M. M. L., and Hildreth, J. E. K. HIV-induced loss of CD44 expression in monocytic cell lines. J. Immunol., 151: 2225-2236, 1993.
39. Hildreth, J. E., and August, J. T. The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. J. Immunol., 134: 3272-3280, 1985.
40. Brigati, D. J., Budgeon, L. R., Unger, E. R., Koebler, D., Cuomo, C., Kennedy, T., and Perdomo, J. M. I. Immunocytochemistry is automated: development of a robotic workstation based upon the capillary action principle. J. Histotechnol., 11: 165-183, 1988.
41. Shi, S. R., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
42. Taylor, C. R., Shi, S. R., Chaiwun, B., Young, L., Imam, S. A., and Cote, R. J. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum. Pathol., 25: 263-270, 1994.
43. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
44. Mantel, N., and Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22: 719-748, 1959.
45. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 34: 187-220, 1972.
46. Efron, B., and Tibshirani, R. An Introduction to The Bootstrap. New York: Chapman and Hall, 1993.
47. Harrell, F. E., Lee, K. L., and Mark, D. B. Multivariable Prognostic Models. Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med., 15: 361-387, 1996.
48. SAS Institute Inc. SAS User's Guide: Statistics, 5th Ed. Cary, NC: SAS Institute Inc., 1985.
49. Statistics and Epidemiology Research Corp. EGRET User's Manual. Seattle, WA: Statistics and Epidemiology Research Corp., 1988.
50. Lucas, M. G., Green, A. M., and Telen, M. J. Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80. Blood, 73: 596-600, 1989.
51. Yang, H., and Binns, R. M. Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules. Immunology, 78: 547-554, 1993.
52. Haynes, B. F., Hale, L. P., Patton, K. L., Martin, M. E., and McCallum, R. M. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum., 34: 1434-1443, 1991.
53. Brown, T. A., Bouchard, T., St. John, T., Wayner, E., and Carter, W. G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113: 207-221, 1991.
54. Haggerty, J. G., Bretton, R. H., and Milstone, L. M. Identification and characterization of a cell surface proteoglycan on keratinocytes. J. Invest Dermatol., 99: 374-380, 1992.
55. Katoh, S., McCarthy, J. B., and Kincade, P. W. Characterization of soluble CD44 in the circulation of mice: levels are affected by immune activity and tumor growth. J. Immunol., 153: 3440-3449, 1994.
56. Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R., and Trotter, J. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics, 15: 299-312, 1982.
57. Hughes, E. N., Colombatti, A., and August, J. T. Murine cell surface glycoproteins. Purification of the polymorphic Pgp-1 antigen and analysis of its expression on macrophages and other myeloid cells. J. Biol. Chem., 258: 1014-1021, 1983.
58. Finke, L. H., Terpe, H. J., Zorb, C., Haensch, W., and Schlag, P. M. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 345: 583, 1995.
59. Koretz, K., Moller, P., Lehnert, T., Hinz, U., Otto, H. F., and Herfarth, C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet, 345: 327-328, 1995.
60. Jackson, P. A., Green, M. A., Pouli, A., Hubbard, R., Marks, C. G., and Cook, M. G. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J. Clin. Pathol., 48: 1098-1101, 1995.
61. Gotley, D. C., Fawcett, J., Walsh, M. D., Reeder, J. A., Simmons, D. L., and Antalis, T. M. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br. J. Cancer, 74: 342-351, 1996.
62. Fox, S. B., Fawcett, J., Jackson, D. G., Collins, I., Gatter, K. C., Harris, A. L., Gearing, A., and Simmons, D. L. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res., 54: 4539-4546, 1994.
63. Mackay, C. R., Terpe, H. J., Stauder, R., Marston, W. L., Stark, H., and Gunthert, U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124: 71-82, 1994.
64. Terpe, H. J., Stark, H., Prehm, P., and Gunthert, U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry, 101: 79-89, 1994.
65. Sy, M. S., Guo, Y. J., and Stamenkovic, I. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med., 176: 623-627, 1992.